Perpetual neuroinflammation is the core neurological challenge in autism. Mitochondrial insufficiency is the core cause of the perpetual nature of the inflammation. Delayed and dysfunctional myelination is the core consequence of the perpetual neuroinflammation. A core component of myelin is a phospholipid called plasmalogen. Myelin development is dependent upon sufficient intra-brain biosynthesis of plasmalogens in oligodendrocytes. The primary source of nutritional supplementation of plasmalogens is via plasmalogen precursors that are present in human breast milk (but not cow’s milk or formula). Circulating and other dietary sources of plasmalogens are generally unavailable to the brain. Recently, nutritional supplementation of plasmalogen precursors identical to those found in human breast milk have become available. These plasmalogen precursors either alone or in combination with specific mitochondrial supplements have been found to be effective in children and adults with autism. This lecture will provide an overview of the biochemistry and neurology of autism and how new research that specifically targets myelin and mitochondrial restoration is showing positive results in autism.
Over the past 30 years, Dr. Dayan Goodenowe has invented and developed advanced diagnostic and bioinformatic technologies, designed and manufactured novel and natural biochemical precursors, and identified a treasure trove of biochemical markers that predict numerous diseases including Alzheimer’s and dementia, Parkinson’s, multiple sclerosis, stroke, autism, ALS, multiple system atrophy, various mental illnesses, and cancers. The study of Plasmalogens is vital in predicting several diseases. Plasmalogens are critical membrane components that help cells communicate with each other and function harmoniously. I have studied Plasmalogens since 2006, and research has expanded to show that Plasmalogens are the root cause of neurodegeneration that leads to Alzheimer’s, Parkinson’s, and MS. Dr. Goodenowe’s passion is to educate the world about the life-extending benefits possible when Plasmalogen health is harnessed.
